Insider Buying: CVS Group (LON:CVSG) Insider Buys £9,937.92 in Stock

CVS Group plc (LON:CVSG) insider Robin Alfonso bought 768 shares of the company’s stock in a transaction on Thursday, August 6th. The stock was bought at an average price of GBX 1,294 per share, for a total transaction of £9,937.92.

CVS Group Trading Up 0.2%

Shares of CVSG stock opened at GBX 1,300 on Friday. The firm has a market cap of £889.76 million, a P/E ratio of 18.87, a PEG ratio of 1.77 and a beta of 1.06. The company has a quick ratio of 0.90, a current ratio of 1.07 and a debt-to-equity ratio of 92.34. The company has a 50 day moving average of GBX 1,233.99 and a 200-day moving average of GBX 1,242.36. CVS Group plc has a 12-month low of GBX 1,062 and a 12-month high of GBX 1,648.

CVS Group declared that its board has initiated a stock repurchase plan on Tuesday, May 26th that allows the company to repurchase 0 outstanding shares. This repurchase authorization allows the company to repurchase shares of its stock through open market purchases. Shares repurchase plans are generally a sign that the company’s management believes its stock is undervalued.

Wall Street Analyst Weigh In

A number of research firms have commented on CVSG. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a GBX 1,700 target price on shares of CVS Group in a report on Monday, July 27th. Berenberg Bank reaffirmed a “buy” rating and set a GBX 2,000 price target on shares of CVS Group in a report on Thursday, July 23rd. Finally, Jefferies Financial Group increased their price objective on CVS Group from GBX 1,350 to GBX 1,400 and gave the company a “hold” rating in a research report on Friday, July 31st. Four analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of GBX 1,720.

CVS Group Company Profile

CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business (“Animed Direct”).

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.